Biodesix, Inc.
Biodesix, Inc.（BDSX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · BDSX · 截至 2026年6月9日
活动摘要
买入笔数
9
P-Purchase only
卖出笔数
35
近12个月
买卖比
0.26
Buy/Sell (by trades)
整体情绪
Biodesix, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
BDSX 季度内部人买卖趋势
BDSX 内幕交易卖出 · BDSX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · BDSX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
BDSX 高管卖出股份 · BDSX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 31, 2026 | PATIENCE JOHN Director | Option | 1,361 | — | Form 4 |
| Feb 20, 2026 | Pestano Gary Anthony Chief Development Officer | Option | 1,528 | — | Form 4 |
| Feb 23, 2026 | Pestano Gary Anthony Chief Development Officer | Sale | 556 | $7K | Form 4 |
| Feb 20, 2026 | O'Kane Kieran Chief Commercial Officer | Option | 1,469 | — | Form 4 |
| Feb 23, 2026 | O'Kane Kieran Chief Commercial Officer | Sale | 535 | $7K | Form 4 |
| Feb 20, 2026 | Cowie Robin Harper CFO, Sec'y & Treasurer | Option | 1,469 | — | Form 4 |
| Feb 23, 2026 | Cowie Robin Harper CFO, Sec'y & Treasurer | Sale | 535 | $7K | Form 4 |
| Feb 20, 2026 | Vazquez Chris CAO | Option | 563 | — | Form 4 |
| Feb 23, 2026 | Vazquez Chris CAO | Sale | 211 | $3K | Form 4 |
| Feb 20, 2026 | Hutton Scott President & CEO · Director | Option | 4,844 | — | Form 4 |
| Feb 23, 2026 | Hutton Scott President & CEO · Director | Sale | 1,490 | $19K | Form 4 |
| Feb 9, 2026 | O'Kane Kieran Chief Commercial Officer | Option | 1,600 | — | Form 4 |
| Feb 10, 2026 | O'Kane Kieran Chief Commercial Officer | Sale | 584 | $6K | Form 4 |
| Feb 9, 2026 | Vazquez Chris CAO | Option | 263 | — | Form 4 |
| Feb 10, 2026 | Vazquez Chris CAO | Sale | 101 | $1K | Form 4 |
| Feb 9, 2026 | Hutton Scott President & CEO · Director | Option | 9,998 | — | Form 4 |
| Feb 10, 2026 | Hutton Scott President & CEO · Director | Sale | 3,559 | $36K | Form 4 |
| Feb 9, 2026 | Cowie Robin Harper CFO, Sec'y & Treasurer | Option | 2,584 | — | Form 4 |
| Feb 10, 2026 | Cowie Robin Harper CFO, Sec'y & Treasurer | Sale | 941 | $9K | Form 4 |
| Feb 9, 2026 | Pestano Gary Anthony Chief Development Officer | Option | 1,481 | — | Form 4 |
| Feb 10, 2026 | Pestano Gary Anthony Chief Development Officer | Sale | 540 | $5K | Form 4 |
| Jan 26, 2026 | SCHULER JACK W Director | Purchase | 20,000 | $236K | Form 4 |
| Jan 23, 2026 | SCHULER JACK W Director | Purchase | 80,000 | $945K | Form 4 |
| Jan 22, 2026 | SCHULER JACK W Director | Purchase | 82,465 | $904K | Form 4 |
| Jan 15, 2026 | Vazquez Chris CAO | Option | 219 | — | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 BDSX 内幕交易
BDSX 内幕交易
Biodesix, Inc.（BDSX）内幕交易数据来源于公司内部人（包括Cowie Robin Harper (CFO, Sec'y & Treasurer), Hutton Scott (President & CEO · Director), Pestano Gary Anthony (Chief Development Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。BDSX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Biodesix, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
BDSX 内幕交易 · 5个问题Biodesix, Inc.（BDSX）的内部人包括高管和董事，如Cowie Robin Harper (CFO, Sec'y & Treasurer), Hutton Scott (President & CEO · Director), Pestano Gary Anthony (Chief Development Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026